Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
| CAPS Rating |
|
|---|---|
| Open | $9.44 |
| Previous Close | $9.56 |
| Daily Range | $9.31 - $9.59 |
| 52-Week Range | $6.42 - $10.60 |
| Market Cap | $671.64M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 157,068 |
| Average Daily Volume | 0 |
RIGL
VS S&P 500 (SPY)
How do you think RIGL will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
RIGL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
RIGL News and Commentary
- The 2 Best-Performing Sectors Over the Last Decade – The Motley Fool
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – NASDAQ
- Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most – The Motley Fool
- The New Pfizer: 6 Drug Companies With Bullish Short Trends – The Motley Fool
- Mini J&J? I Guess Not – The Motley Fool
- Better Late Than Never? Maybe. – The Motley Fool
- In-Licensing to the Rescue – The Motley Fool
- 11 Incredible Dividend Stocks: Abbott Labs – The Motley Fool
- High-Flying Stocks: 5 Longs & 4 Shorts – Blog at The Motley Fool
- Losing Biobucks as Pharma Reshuffles Its Deck – SeekingAlpha
- Stocks Rally on New Jobs Data; Oil Adds Back Some of Prior-Session Loss – NASDAQ
- Mid-Day Update: Stocks Rally on Better-Than-Expected Jobs Report; Commodities Gain – NASDAQ
- A Dedication to R&D Means These Stocks Could See Robust Growth – SeekingAlpha
- Dark Clouds Lift Over Pharma Dispute – The Motley Fool
- Pfizer Needs Rheumatoid Arthritis Drug to Keep Performing – SeekingAlpha
- Pfizer's Biggest Shot at Lipitor 2.0 – The Motley Fool
- The Most Important Thing Affecting Merck – The Motley Fool
- 6 Stocks Near Lows With Rising Call Volume – NASDAQ
- Abbott Labs: Growth in All the Wrong Places – The Motley Fool
- INTERVIEW: AstraZeneca R&D Chief Seeks Alliances, In-Licencing – SmartMoney
RSS Headlines
Fool UK
